Avinger (AVGR) Stock Price, News & Analysis

Company Overview

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.

Key Stats

• Today's Range: $0.47 to $0.47
• 50-Day Range: $0.47 to $0.47
• 52-Week Range: $0.36 to $3.04
• Volume: N/A
• Average Volume: 1.14 million shs
• Market Capitalization: $1.57 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AVGR Stock Analysis - Frequently Asked Questions

How have AVGR shares performed this year?

Avinger's stock was trading at $0.8180 at the beginning of the year. Since then, AVGR stock has decreased by 42.1% and is now trading at $0.4740.
View the best growth stocks for 2025 here.

How were Avinger's earnings last quarter?

Avinger, Inc. (NASDAQ:AVGR) posted its quarterly earnings data on Thursday, November, 7th. The medical device company reported ($1.82) EPS for the quarter, topping analysts' consensus estimates of ($2.03) by $0.21. The medical device company earned $1.65 million during the quarter, compared to analysts' expectations of $1.60 million. Avinger had a negative net margin of 261.06% and a negative trailing twelve-month return on equity of 5,527.11%.
Read the conference call transcript.

When did Avinger's stock split?

Avinger shares reverse split on Wednesday, September 13th 2023. The 1-15 reverse split was announced on Wednesday, September 13th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, September 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

When did Avinger IPO?

Avinger (AVGR) raised $60 million in an initial public offering (IPO) on Friday, January 30th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company served as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.

How do I buy shares of Avinger?

Shares of AVGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Avinger own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Avinger investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), CrowdStrike (CRWD), GE Aerospace (GE) and Broadcom (AVGO).

Company Calendar

• Last Earnings: 11/07/2024
• Today: 5/23/2025
• Next Earnings (Estimated): 8/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:AVGR
• CIK: 1506928
• Web: www.avinger.com
• Phone: (650) 241-7900
• Fax: 800-229-2696
• Employees: 70
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($11.06)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-18,320,000.00
• Net Margins: -261.06%
• Pretax Margin: -256.25%
• Return on Equity: -5,527.11%
• Return on Assets: -123.25%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.21
• Quick Ratio: 0.81

Sales & Book Value

• Annual Sales: $7.26 million
• Price / Sales: 0.22
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($4.53) per share
• Price / Book: -0.10

Miscellaneous

• Outstanding Shares: 3,309,000
• Free Float: 1,893,000
• Market Cap: $1.57 million
• Optionable: Not Optionable
• Beta: 1.09